Researchers identify distinct molecular and immune profiles that impact the prognosis of patients with metastatic pancreatic ductal adenocarcinoma.

THE Nolan Sisters know firsthand just how devastating cancer can be with the family bravely battling against the “cursed” ...

Researchers developed an AI model that predicts brain metastasis invasion patterns with 85% accuracy, offering a noninvasive ...

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients' cancer without aggressive surgery.

An elderly Englishman got diagnosed with prostate cancer after he went to a dentist to get his recurrent toothache treated. According to experts, despite the doctor extracting his tooth, he continued ...

Kenneth Dootson, of Marlborough, died prematurely at age 75 because of Yale's misdiagnosis of cancer that had spread to his ...

Real-world data supports Opdivo plus Yervoy efficacy for advanced renal cell carcinoma, mirroring clinical trial results.

Hoag physicians testing promising options for the diagnosis and treatment of glioblastoma (GBM), the deadliest form of brain cancer The LIBERATE study (NCT05383872), sponsored by INSIGHTEC, evaluates ...

Background The immune suppression mechanisms in pancreatic ductal adenocarcinoma (PDAC) remain unknown, but preclinical ...

Manmeet Ahluwalia, MD, MBA, FASCO, discusses the prevalence of brain metastases in patients with primary renal cell carcinoma.

Preoperative stereotactic radiosurgery to treat brain metastases resulted in low rates of local recurrence, radionecrosis, ...

Utidelone is under clinical development by BioStar Pharmaceuticals and currently in Phase I for Non-Small Cell Lung Cancer.